Study Shows Contrast Ultrasound Improves Treatment for Deadly Liver Cancers
Sep. 07, 2018
CHICAGO--(BUSINESS WIRE)--Sep 7, 2018--Tiny microbubbles are being used to more effectively treat liver cancer, according to a pilot study described Wednesday at the 33rd annual Advances in Contrast Ultrasound conference in Chicago.
Patients with hepatocellular carcinoma (HCC), the third leading cause of cancer deaths worldwide, were found to benefit from a combination of contrast enhanced ultrasound (CEUS) and radiation therapy, according to Dr. John Eisenbrey, a researcher at Thomas Jefferson University in Philadelphia.
"These are exciting preliminary findings because hepatocellular carcinoma is the most common form of liver cancer, and microbubbles appear to sensitize the tumor to the radiation therapy," Dr. Eisenbrey said.
For many years CEUS has used liquid suspensions of tiny gas microbubbles to improve the clarity and reliability of diagnostic ultrasound images of the heart, liver and other organ systems. The Thomas Jefferson study found that these ultrasound contrast agents can also be used to improve the effectiveness of cancer therapy, with the microbubbles playing a role in tumor death.
The study included one set of patients with liver cancer treated with radiation therapy alone and a second set of patients that received radiation therapy combined with CEUS.
Researchers found that patients receiving a combination of CEUS and radiation saw destruction of the vessels that carry blood to the tumor, with a 25 to 60% increased response to the radiation treatment.
"The microbubbles produced a clear therapeutic benefit," Eisenbrey said.
"These findings are extremely exciting and appear to be consistent with previous work using the microbubbles to enhance absorption of chemotherapy drugs,” according to Dr. Steven Feinstein, Co-President of ICUS and a professor of medicine at Rush University Medical Center in Chicago.
"Microbubble contrast agents are extremely safe and useful for diagnostic ultrasound imaging, and their new therapeutic uses are very promising," Feinstein said.
ICUS is an international medical society that is dedicated to advancing the appropriate use of contrast enhanced ultrasound to improve patient care. ICUS members include physicians, scientists, and other ultrasound imaging professionals in approximately 60 countries. For more information about ICUS, please visit .
View source version on businesswire.com:https://www.businesswire.com/news/home/20180907005345/en/
CONTACT: International Contrast Ultrasound Society
Mark W. Weller, 202-276-7421 or 202-626-8363
Linda M. Feinstein, 847-624-1844 or 312-876-2563
KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS
INDUSTRY KEYWORD: HEALTH HOSPITALS MEDICAL DEVICES ONCOLOGY RADIOLOGY RESEARCH SCIENCE
SOURCE: International Contrast Ultrasound Society
Copyright Business Wire 2018.
PUB: 09/07/2018 11:38 AM/DISC: 09/07/2018 11:38 AM